Gendoo

MeSH keywords -> Related genes, diseases (OMIM)


Query MeSH keywords list

01 Follow-Up Studies [NCBI]

Gene


 Gene Link Information
Gain		 01



OMIM


 OMIM Link Information
gain		 01
VRNI [NCBI] 0.00960907
IS1 [NCBI] 0.00664576
apnea, obstructive sleep [NCBI] 0.00589202
KLK3 [NCBI] 0.00565787
CEACAM5 [NCBI] 0.00195571
klippel-trenaunay-weber syndrome [NCBI] 0.00130931
RA [NCBI] 0.00119949
dubowitz syndrome [NCBI] 0.00110247
deafness, progressive high-tone neural [NCBI] 0.00107848
TG [NCBI] 0.00106804
MDD [NCBI] 0.000950803
thrombocytopenic purpura, autoimmune [NCBI] 0.000757518
IDDM [NCBI] 0.000667588
AFP [NCBI] 0.000591149
MRX52 [NCBI] 0.000566896
MCOPS10 [NCBI] 0.000566896
palatopharyngeal incompetence [NCBI] 0.000529911
glomerulopathy with fibronectin deposits [NCBI] 0.00052081
DFSP [NCBI] 0.000467488
OD [NCBI] 0.000459461
EOCA [NCBI] 0.000444062
PFHB1B [NCBI] 0.000444062
SLE [NCBI] 0.000398276
TAPVR1 [NCBI] 0.00038362
kohlschutter-tonz syndrome [NCBI] 0.00038362
behcet syndrome [NCBI] 0.000375648
MAFD6 [NCBI] 0.000374953
PTH [NCBI] 0.000355465
APC [NCBI] 0.000327035
brachial palsy, familial congenital [NCBI] 0.000311814
acne inversa, familial [NCBI] 0.000311814
auriculocondylar syndrome [NCBI] 0.000311814
volvulus of midgut [NCBI] 0.000311814
hypogonadism, alopecia, diabetes mellitus, mental retardation, and extrapyramidal syndrome [NCBI] 0.000311814
nablus mask-like facial syndrome [NCBI] 0.000311814
trichomegaly with mental retardation, dwarfism, and pigmentary degeneration of retina [NCBI] 0.000311814
ehlers-danlos syndrome, type v [NCBI] 0.000311814
spastic diplegia, infantile type [NCBI] 0.000311814
MG [NCBI] 0.000309634
lymphoma, non-hodgkin, familial [NCBI] 0.000306309
CDB2 [NCBI] 0.000292993
DWS [NCBI] 0.000278637
dermatitis, atopic [NCBI] 0.000257834
FA [NCBI] 0.000248199
EGF [NCBI] 0.000245723
NGFB [NCBI] 0.000234443
PDR [NCBI] 0.000221846
vitreoretinal degeneration, snowflake type [NCBI] 0.000221846
MHAC [NCBI] 0.000221846
trichohepatoenteric syndrome [NCBI] 0.000221846
macular dystrophy, butterfly-shaped pigmentary, 2 [NCBI] 0.000221846
cerebellar atrophy with progressive microcephaly [NCBI] 0.000221846
hypoadrenocorticism, familial [NCBI] 0.000221846
megalencephaly [NCBI] 0.000221846
GHDD [NCBI] 0.000221846
cataract, age-related cortical [NCBI] 0.000221846
SPG9 [NCBI] 0.000221846
patent ductus arteriosus [NCBI] 0.000221846
SCAR6 [NCBI] 0.000221846
GIST [NCBI] 0.000219302
temporal arteritis [NCBI] 0.000202651
SRS [NCBI] 0.000202032
ACPP [NCBI] 0.000184983
CF [NCBI] 0.000171367
VDEGS [NCBI] 0.000166975
spinal muscular atrophy, distal, congenital nonprogressive [NCBI] 0.000166975
POADS [NCBI] 0.000166975
RP6 [NCBI] 0.000166975
TKCR [NCBI] 0.000166975
RP24 [NCBI] 0.000166975
MPD2 [NCBI] 0.000166975
cholestasis-lymphedema syndrome [NCBI] 0.000166975
prosopagnosia, hereditary [NCBI] 0.000166975
amyotrophy, neurogenic scapuloperoneal, new england type [NCBI] 0.000166975
ichthyosis follicularis, atrichia, and photophobia syndrome [NCBI] 0.000166975
endometriosis, susceptibility to, 1 [NCBI] 0.000166975
kbg syndrome [NCBI] 0.000166975
sneddon syndrome [NCBI] 0.000166975
AT [NCBI] 0.000155714
TH [NCBI] 0.000151084
LAM [NCBI] 0.000145401
pars planitis [NCBI] 0.000143052
NPY [NCBI] 0.000129885
HBD [NCBI] 0.000128774
larsen syndrome, recessive [NCBI] 0.000128774
BZX [NCBI] 0.000128774
hereditary motor and sensory neuropathy, type iic [NCBI] 0.000128774
gapo syndrome [NCBI] 0.000128774
carney triad [NCBI] 0.000121608
HFM [NCBI] 0.000121453
PCNA [NCBI] 0.00012109
CRMO [NCBI] 0.000120434
CRC [NCBI] 0.000116625
IFNA1 [NCBI] 0.000115013
APOE [NCBI] 0.000114787
SJS1 [NCBI] 0.000111446
aortic valve disease [NCBI] 0.000111004
MUC1 [NCBI] 0.000105303
MJD [NCBI] 0.000104709
geleophysic dysplasia [NCBI] 0.000100392
SEMDJL [NCBI] 0.000100392
OSCS [NCBI] 0.000100392
NNO1 [NCBI] 0.000100392
HMN7A [NCBI] 0.000100392
neutrophilic dermatosis, acute febrile [NCBI] 0.000100392
CLN4A [NCBI] 0.000100392
kyphomelic dysplasia [NCBI] 0.000100392
IOSCA [NCBI] 0.000100392
fanconi renotubular syndrome [NCBI] 0.000100392
PGL2 [NCBI] 0.000100392
OCP [NCBI] 9.70507e-05
DGS [NCBI] 9.66545e-05
LSA [NCBI] 9.55135e-05
PGR [NCBI] 9.53072e-05
PDV [NCBI] 9.50719e-05
IGAN1 [NCBI] 9.49184e-05
ATD1 [NCBI] 9.49184e-05
BDNF [NCBI] 9.2843e-05
dystrophia myotonica 1 [NCBI] 9.15217e-05
CJD [NCBI] 8.93256e-05
PD [NCBI] 8.88792e-05
fundus dystrophy, pseudoinflammatory, recessive form [NCBI] 8.74515e-05
colloid cysts of third ventricle [NCBI] 8.74515e-05
fragile x mental retardation syndrome [NCBI] 8.55723e-05
hemophagocytic lymphohistiocytosis, familial, 1 [NCBI] 8.19301e-05
AVP [NCBI] 8.00682e-05
RNASE3 [NCBI] 7.95029e-05
IH [NCBI] 7.84989e-05
acrodysostosis [NCBI] 7.84989e-05
DA5 [NCBI] 7.84989e-05
thyroid carcinoma, nonmedullary, with or without cell oxyphilia [NCBI] 7.84989e-05
MNG1 [NCBI] 7.84989e-05
EGFR [NCBI] 7.76249e-05
CHAT [NCBI] 7.56257e-05
CRH [NCBI] 7.3096e-05
VUR1 [NCBI] 7.25803e-05
JBTS1 [NCBI] 7.25803e-05
stuve-wiedemann syndrome [NCBI] 7.11882e-05
VIP [NCBI] 7.06364e-05
AMC [NCBI] 7.02991e-05
SMAX1 [NCBI] 6.92538e-05
DHFR [NCBI] 6.85493e-05
CD [NCBI] 6.81321e-05
MAFD1 [NCBI] 6.64098e-05
MODY [NCBI] 6.44478e-05
DMD [NCBI] 6.40129e-05
TS [NCBI] 6.25317e-05
retinal dystrophy, reticular pigmentary, of posterior pole [NCBI] 6.23965e-05
cerebellar ataxia and neurosensory deafness [NCBI] 6.23965e-05
pericardial effusion, chronic [NCBI] 6.23965e-05
cysteine peptiduria [NCBI] 6.23965e-05
cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss [NCBI] 6.23965e-05
noonan-like syndrome with loose anagen hair [NCBI] 6.23965e-05
holoprosencephaly, ectrodactyly, and bilateral cleft lip/palate [NCBI] 6.23965e-05
metaphyseal chondrodysplasia with retinitis pigmentosa [NCBI] 6.23965e-05
intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies [NCBI] 6.23965e-05
hyaluronan metabolism, defect in [NCBI] 6.23965e-05
osteogenesis imperfecta, sillence type ii/iii, without abnormality of type i collagen [NCBI] 6.23965e-05
calvarial hyperostosis [NCBI] 6.23965e-05
curved nail of fourth toe [NCBI] 6.23965e-05
whispering dysphonia, hereditary [NCBI] 6.23965e-05
choroidal osteoma, bilateral [NCBI] 6.23965e-05
frontoocular syndrome [NCBI] 6.23965e-05
renal tubular acidosis, proximal [NCBI] 6.23965e-05
charge-like syndrome, x-linked [NCBI] 6.23965e-05
trichodiscomas, familial multiple [NCBI] 6.23965e-05
anemia, congenital hypoplastic, with multiple congenital anomalies/mental retardation syndrome [NCBI] 6.23965e-05
aplasia cutis congenita with epibulbar dermoids [NCBI] 6.23965e-05
scott craniodigital syndrome with mental retardation [NCBI] 6.23965e-05
odontoma-dysphagia syndrome [NCBI] 6.23965e-05
simosa craniofacial syndrome [NCBI] 6.23965e-05
superior transverse scapular ligament, calcification of, familial [NCBI] 6.23965e-05
VEGF [NCBI] 6.18872e-05
microtia with meatal atresia and conductive deafness [NCBI] 6.12176e-05
CGF [NCBI] 6.12176e-05
ANON1 [NCBI] 6.12176e-05
RCD1 [NCBI] 6.12176e-05
neutropenia, chronic familial [NCBI] 6.12176e-05
GO [NCBI] 6.12176e-05
pulmonary disease, chronic obstructive [NCBI] 6.12176e-05
AVSD [NCBI] 6.03763e-05
ablepharon-macrostomia syndrome [NCBI] 6.01099e-05
ramon syndrome [NCBI] 6.01099e-05
ACHE [NCBI] 5.82478e-05
RTT [NCBI] 5.80773e-05
BL [NCBI] 5.45163e-05
WAS [NCBI] 5.39412e-05
CFTR [NCBI] 5.32161e-05
autism [NCBI] 5.29366e-05
BBS [NCBI] 5.26669e-05
KSS [NCBI] 5.26669e-05
urogenital adysplasia, hereditary [NCBI] 4.8223e-05
PTK2 [NCBI] 4.79273e-05
myasthenic syndrome, congenital, associated with episodic apnea [NCBI] 4.77389e-05
CMTC [NCBI] 4.77389e-05
SMS [NCBI] 4.75293e-05
mohr syndrome [NCBI] 4.73849e-05
spinocerebellar ataxia 29 [NCBI] 4.73849e-05
avascular necrosis of femoral head, primary [NCBI] 4.5444e-05
BFH [NCBI] 4.5444e-05
CAT [NCBI] 4.54364e-05
FRDA [NCBI] 4.39097e-05
SHH [NCBI] 4.36459e-05
PPARA [NCBI] 4.29884e-05
TNF [NCBI] 4.18797e-05
COMP [NCBI] 4.17442e-05
neuropathy, congenital hypomyelinating [NCBI] 4.12243e-05
amyloidosis vi [NCBI] 4.05135e-05
AHR [NCBI] 4.01885e-05
PJS [NCBI] 4.00993e-05
giant platelet syndrome [NCBI] 3.82163e-05
PWS [NCBI] 3.81427e-05
B2M [NCBI] 3.78189e-05
HBB [NCBI] 3.75822e-05
PRKCH [NCBI] 3.73178e-05
CCK [NCBI] 3.72065e-05
RTS [NCBI] 3.69247e-05
AR [NCBI] 3.65642e-05
corneal dystrophy, crystalline, of schnyder [NCBI] 3.62295e-05
PARK3 [NCBI] 3.62295e-05
ZLS [NCBI] 3.62295e-05
PCA [NCBI] 3.62295e-05
varadi-papp syndrome [NCBI] 3.62295e-05
WM1 [NCBI] 3.62295e-05
AD [NCBI] 3.58899e-05
EBN1 [NCBI] 3.57287e-05
aspirin resistance [NCBI] 3.56539e-05
c syndrome [NCBI] 3.56539e-05
gigantiform cementoma, familial [NCBI] 3.55324e-05
LOCS [NCBI] 3.55324e-05
cerebellotrigeminal dermal dysplasia [NCBI] 3.55324e-05
craniomicromelic syndrome [NCBI] 3.55324e-05
kniest-like dysplasia with pursed lips and ectopia lentis [NCBI] 3.55324e-05
ectodermal dysplasia, hypohidrotic, with hypothyroidism and agenesis of the corpus callosum [NCBI] 3.55324e-05
anauxetic dysplasia [NCBI] 3.55324e-05
nephrosialidosis [NCBI] 3.55324e-05
paraganglioma and gastric stromal sarcoma [NCBI] 3.55324e-05
ulna metaphyseal dysplasia syndrome [NCBI] 3.55324e-05
lumbar stenosis, familial [NCBI] 3.55324e-05
MRX45 [NCBI] 3.55324e-05
craniosynostosis with fibular aplasia [NCBI] 3.55324e-05
retinopathy, pericentral pigmentary, autosomal recessive [NCBI] 3.55324e-05
hirsutism--skeletal dysplasia--mental retardation syndrome [NCBI] 3.55324e-05
spondylometaepiphyseal dysplasia, short limb-hand type [NCBI] 3.55324e-05
dandy-walker malformation with postaxial polydactyly [NCBI] 3.55324e-05
papillary thyroid microcarcinoma [NCBI] 3.55324e-05
optic atrophy 3, autosomal dominant [NCBI] 3.55324e-05
EPS [NCBI] 3.55324e-05
kleeblattschaedel syndrome [NCBI] 3.55324e-05
epileptic encephalopathy, lennox-gastaut type [NCBI] 3.55324e-05
FFI [NCBI] 3.54203e-05
WT1 [NCBI] 3.4727e-05
kabuki syndrome [NCBI] 3.45748e-05
polycystic kidneys [NCBI] 3.45421e-05
AS [NCBI] 3.45421e-05
CMH [NCBI] 3.45374e-05
AOS [NCBI] 3.38109e-05
GFAP [NCBI] 3.35349e-05
fabry disease [NCBI] 3.33478e-05
stroke, ischemic [NCBI] 3.32904e-05
GNRH1 [NCBI] 3.30974e-05
RP [NCBI] 3.20993e-05
POMC [NCBI] 3.1837e-05
hyperoxaluria, primary, type i [NCBI] 3.10292e-05
KRT20 [NCBI] 3.07379e-05
CCNE1 [NCBI] 3.04687e-05
FRAP1 [NCBI] 2.95194e-05
XDH [NCBI] 2.8655e-05
HSS [NCBI] 2.84941e-05
TNFSF6 [NCBI] 2.76602e-05
facial ectodermal dysplasia [NCBI] 2.72132e-05
WDM [NCBI] 2.72132e-05
acroosteolysis with osteoporosis and changes in skull and mandible [NCBI] 2.72132e-05
dandy-walker-like malformation with atrioventricular septal defect [NCBI] 2.72132e-05
MLC [NCBI] 2.69693e-05
CHS [NCBI] 2.63839e-05
ALPS2A [NCBI] 2.59592e-05
muscular dystrophy, congenital, with severe central nervous system atrophy and absence of large myelinated fibers [NCBI] 2.59592e-05
pierre robin syndrome [NCBI] 2.59592e-05
pterygia, mental retardation, and distinctive craniofacial features [NCBI] 2.59592e-05
breasts and nipples, absence of [NCBI] 2.59592e-05
ventricular tachycardia, familial [NCBI] 2.59592e-05
cataract, age-related nuclear [NCBI] 2.59592e-05
split-foot deformity with mandibulofacial dysostosis [NCBI] 2.59592e-05
lathosterolosis [NCBI] 2.59592e-05
hydrocephalus due to congenital stenosis of aqueduct of sylvius [NCBI] 2.59592e-05
zunich neuroectodermal syndrome [NCBI] 2.59592e-05
zinc in breast milk, reduced [NCBI] 2.59592e-05
BLM [NCBI] 2.59551e-05
EPO [NCBI] 2.56124e-05
CDA [NCBI] 2.55731e-05
thrombasthenia of glanzmann and naegeli [NCBI] 2.53012e-05
leber optic atrophy [NCBI] 2.50441e-05
GAPDH [NCBI] 2.43832e-05
panencephalitis, subacute sclerosing [NCBI] 2.36431e-05
FRNS [NCBI] 2.34513e-05
NEM3 [NCBI] 2.34343e-05
PDCD1LG1 [NCBI] 2.32435e-05
wolff-parkinson-white syndrome [NCBI] 2.29875e-05
bartter syndrome, antenatal, type 2 [NCBI] 2.29875e-05
breast cancer [NCBI] 2.20833e-05
LCN2 [NCBI] 2.19759e-05
FTD [NCBI] 2.19392e-05
LKS [NCBI] 2.18373e-05
SCA2 [NCBI] 2.14508e-05
aspartylglucosaminuria [NCBI] 2.08136e-05
WGN1 [NCBI] 2.0683e-05
alpers diffuse degeneration of cerebral gray matter with hepatic cirrhosis [NCBI] 2.0683e-05
JBS [NCBI] 2.0683e-05
NPPA [NCBI] 2.05978e-05
TYMS [NCBI] 2.02489e-05
PSACH [NCBI] 2.01978e-05
bile acid synthesis defect, congenital, 1 [NCBI] 2.00613e-05
kanzaki disease [NCBI] 2.00613e-05
sick sinus syndrome, autosomal dominant [NCBI] 2.00613e-05
carbimazole sensitivity [NCBI] 2.00613e-05
CAMT [NCBI] 2.00613e-05
trigonocephaly, nonsyndromic [NCBI] 2.00613e-05
lenz-majewski hyperostotic dwarfism [NCBI] 2.00613e-05
roussy-levy hereditary areflexic dystasia [NCBI] 2.00613e-05
lactase deficiency, congenital [NCBI] 2.00613e-05
respiratory underresponsiveness to hypoxia and hypercapnia [NCBI] 2.00613e-05
PTLS [NCBI] 2.00613e-05
cleft larynx, posterior [NCBI] 2.00613e-05
alpha-b crystallinopathy [NCBI] 2.00613e-05
myxoma, intracardiac [NCBI] 2.00613e-05
paroxysmal tonic upgaze, benign childhood, with ataxia [NCBI] 2.00613e-05
bilirubin, elevated concentrations of, in serum [NCBI] 2.00613e-05
marshall-smith syndrome [NCBI] 2.00613e-05
DYT2 [NCBI] 1.99454e-05
DSG1 [NCBI] 1.91696e-05
ALS1 [NCBI] 1.89614e-05
MBP [NCBI] 1.89222e-05
holocarboxylase synthetase deficiency [NCBI] 1.86178e-05
SOST [NCBI] 1.86178e-05
PRL [NCBI] 1.86137e-05
hypogonadotropic hypogonadism [NCBI] 1.83497e-05
CMT1A [NCBI] 1.77426e-05
metachromatic leukodystrophy [NCBI] 1.71402e-05
OPMD [NCBI] 1.70755e-05
HPS [NCBI] 1.68577e-05
G6PD [NCBI] 1.67696e-05
LPL [NCBI] 1.63157e-05
IGFALS [NCBI] 1.61698e-05
DBA [NCBI] 1.60801e-05
pulmonary alveolar microlithiasis [NCBI] 1.5909e-05
earlobe crease [NCBI] 1.5909e-05
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type ii [NCBI] 1.5909e-05
PPCRA [NCBI] 1.5909e-05
breath-holding spells [NCBI] 1.5909e-05
formiminotransferase deficiency [NCBI] 1.5909e-05
pseudohypoaldosteronism, type i, autosomal dominant [NCBI] 1.5909e-05
schindler disease, type i [NCBI] 1.5909e-05
desmosterolosis [NCBI] 1.5909e-05
robinow-sorauf syndrome [NCBI] 1.5909e-05
PFIC2 [NCBI] 1.5909e-05
n-acetylglutamate synthase deficiency [NCBI] 1.5909e-05
isoproterenol-mediated vasodilatation [NCBI] 1.5909e-05
shprintzen-goldberg craniosynostosis syndrome [NCBI] 1.5909e-05
MRX54 [NCBI] 1.5909e-05
AVSD2 [NCBI] 1.5909e-05
LCA2 [NCBI] 1.5909e-05
seizures, benign familial neonatal-infantile [NCBI] 1.5909e-05
carpenter syndrome [NCBI] 1.5909e-05
PGL3 [NCBI] 1.5909e-05
hawkinsinuria [NCBI] 1.5909e-05
renal tubular acidosis, proximal, with ocular abnormalities and mental retardation [NCBI] 1.5909e-05
HLA-MT [NCBI] 1.56105e-05
thyroid carcinoma, papillary [NCBI] 1.55363e-05
HGPS [NCBI] 1.53625e-05
MKKS [NCBI] 1.50788e-05
RSMD1 [NCBI] 1.50788e-05
infantile spasm syndrome, x-linked [NCBI] 1.50788e-05
DHRD [NCBI] 1.50788e-05
GACI [NCBI] 1.50788e-05
TFPI [NCBI] 1.49156e-05
MPO [NCBI] 1.477e-05
ACE [NCBI] 1.46556e-05
SELP [NCBI] 1.46341e-05
prostate cancer [NCBI] 1.42036e-05
WHS [NCBI] 1.41425e-05
CD [NCBI] 1.41425e-05
LPI [NCBI] 1.4139e-05
MRD [NCBI] 1.41339e-05
SLC6A3 [NCBI] 1.39135e-05
FXYD5 [NCBI] 1.36546e-05
VTCN1 [NCBI] 1.36546e-05
ZNF81 [NCBI] 1.36546e-05
FBS [NCBI] 1.35564e-05
glucose transport defect, blood-brain barrier [NCBI] 1.35564e-05
SCN1 [NCBI] 1.35564e-05
BGLAP [NCBI] 1.33143e-05
HHT [NCBI] 1.29757e-05
ectodermal dysplasia, hypohidrotic, with immune deficiency [NCBI] 1.27848e-05
DFNA5 [NCBI] 1.27848e-05
PMF [NCBI] 1.27848e-05
LIS2 [NCBI] 1.27848e-05
peroxidase and phospholipid deficiency in eosinophils [NCBI] 1.27848e-05
corneal dystrophy, epithelial basement membrane [NCBI] 1.27848e-05
DFNA1 [NCBI] 1.27848e-05
paget disease, juvenile [NCBI] 1.27848e-05
hairy ears, y-linked [NCBI] 1.27848e-05
PPNAD1 [NCBI] 1.27848e-05
CINCA [NCBI] 1.27848e-05
patterned dystrophy of retinal pigment epithelium [NCBI] 1.27848e-05
hyalinosis, infantile systemic [NCBI] 1.27848e-05
DFNA20 [NCBI] 1.27848e-05
thrombophilia [NCBI] 1.27848e-05
minicore myopathy with external ophthalmoplegia [NCBI] 1.27848e-05
DFNA11 [NCBI] 1.27848e-05
tyrosinemia, type iii [NCBI] 1.27848e-05
GSTM1 [NCBI] 1.25243e-05
SOD2 [NCBI] 1.25239e-05
FGFR3 [NCBI] 1.24211e-05
HD [NCBI] 1.22894e-05
ZS [NCBI] 1.22809e-05
CHI3L1 [NCBI] 1.22171e-05
CCNE2 [NCBI] 1.22171e-05
HRPT1 [NCBI] 1.21733e-05
HNA [NCBI] 1.21733e-05
TNNT2 [NCBI] 1.2157e-05
BPES [NCBI] 1.19556e-05
NF1 [NCBI] 1.187e-05
BWS [NCBI] 1.15981e-05
NPC1 [NCBI] 1.14094e-05
SLS [NCBI] 1.14094e-05
GDNF [NCBI] 1.11716e-05
CD40LG [NCBI] 1.11425e-05
FTSJ1 [NCBI] 1.10848e-05
MTTF [NCBI] 1.10848e-05
RNF139 [NCBI] 1.10848e-05
IL2 [NCBI] 1.10008e-05
mucopolysaccharidosis type iiib [NCBI] 1.09146e-05
PLOSL [NCBI] 1.09146e-05
DA2A [NCBI] 1.09146e-05
KTCN1 [NCBI] 1.09146e-05
glycogen storage disease ixa [NCBI] 1.08303e-05
frontonasal dysplasia [NCBI] 1.034e-05
hyperthyroidism, nonautoimmune [NCBI] 1.034e-05
polymicrogyria, bilateral frontoparietal [NCBI] 1.034e-05
AEXS [NCBI] 1.034e-05
naegeli syndrome [NCBI] 1.034e-05
vater association [NCBI] 1.034e-05
HOMG3 [NCBI] 1.034e-05
valproate embryopathy, susceptibility to [NCBI] 1.034e-05
SPMM [NCBI] 1.034e-05
CPVT [NCBI] 1.034e-05
hemochromatosis, neonatal [NCBI] 1.034e-05
MIA [NCBI] 1.01543e-05
FIP1L1 [NCBI] 1.01543e-05
IL23R [NCBI] 1.01543e-05
MFS [NCBI] 9.93199e-06
PXE [NCBI] 9.79402e-06
CYP1A1 [NCBI] 9.78076e-06
HBFQTL2 [NCBI] 9.77131e-06
restless legs syndrome, susceptibility to, 1 [NCBI] 9.77131e-06
histidinemia [NCBI] 9.76728e-06
UCMD [NCBI] 9.76728e-06
coffin-siris syndrome [NCBI] 9.55405e-06
glycogen storage disease vi [NCBI] 9.36717e-06
SCA7 [NCBI] 9.29461e-06
CLS [NCBI] 9.29461e-06
SPS [NCBI] 9.25684e-06
PSCA [NCBI] 9.179e-06
ATP7A [NCBI] 9.179e-06
ACH [NCBI] 9.16996e-06
factor v deficiency [NCBI] 8.84467e-06
mannosidosis, alpha b, lysosomal [NCBI] 8.72054e-06
CNC1 [NCBI] 8.72054e-06
transcobalamin ii deficiency [NCBI] 8.6999e-06
SLC30A4 [NCBI] 8.68724e-06
GRHPR [NCBI] 8.68724e-06
LDLR [NCBI] 8.50707e-06
cystathioninuria [NCBI] 8.37797e-06
PHA2 [NCBI] 8.37797e-06
hyperferritinemia-cataract syndrome [NCBI] 8.37797e-06
DYT12 [NCBI] 8.37797e-06
AMDM [NCBI] 8.37797e-06
MRX9 [NCBI] 8.37797e-06
mast cell disease [NCBI] 8.37797e-06
PGL4 [NCBI] 8.37797e-06
myoclonic epilepsy, neonatal, with suppression-burst pattern [NCBI] 8.37797e-06
INS [NCBI] 8.31443e-06
TNFRSF11B [NCBI] 8.14797e-06
SLOS [NCBI] 8.12571e-06
SCO2 [NCBI] 8.09053e-06
HPD [NCBI] 8.09053e-06
ELOVL4 [NCBI] 8.09053e-06
melanoma, uveal [NCBI] 8.05558e-06
CGD [NCBI] 8.00846e-06
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency [NCBI] 8.00846e-06
LS [NCBI] 8.00846e-06
galactosemia [NCBI] 7.79027e-06
hodgkin lymphoma [NCBI] 7.76499e-06
CLN1 [NCBI] 7.76499e-06
IP [NCBI] 7.7642e-06
mucopolysaccharidosis type ii [NCBI] 7.58751e-06
CYP27A1 [NCBI] 7.56029e-06
CTSE [NCBI] 7.56029e-06
TREM2 [NCBI] 7.56029e-06
NPPB [NCBI] 7.56029e-06
tyrosinemia, type i [NCBI] 7.4307e-06
MTS [NCBI] 7.38273e-06
FOP [NCBI] 7.38273e-06
HGF [NCBI] 7.25928e-06
MPZ [NCBI] 7.20867e-06
homocystinuria [NCBI] 7.08645e-06
ERAF [NCBI] 7.08439e-06
RDH5 [NCBI] 7.08439e-06
MATN1 [NCBI] 7.08439e-06
EFE [NCBI] 6.89249e-06
HMN2A [NCBI] 6.77701e-06
granulomatous disease, chronic, autosomal recessive, cytochrome b-negative [NCBI] 6.77701e-06
GS2 [NCBI] 6.77701e-06
PLSJ [NCBI] 6.77701e-06
tobacco addiction, susceptibility to [NCBI] 6.77701e-06
GGM [NCBI] 6.77701e-06
VLDLRCH [NCBI] 6.77701e-06
FTC [NCBI] 6.77701e-06
hydrops-ectopic calcification-moth-eaten skeletal dysplasia [NCBI] 6.77701e-06
CMT2D [NCBI] 6.77701e-06
NSHPT [NCBI] 6.77701e-06
3-@methylglutaconic aciduria, type i [NCBI] 6.77701e-06
hypercholesterolemia, autosomal dominant [NCBI] 6.7664e-06
APOB [NCBI] 6.75868e-06
ALB [NCBI] 6.75136e-06
FGF23 [NCBI] 6.70115e-06
USP7 [NCBI] 6.65373e-06
RMRP [NCBI] 6.65373e-06
SGCD [NCBI] 6.65373e-06
NR1I2 [NCBI] 6.34729e-06
LMNA [NCBI] 6.28355e-06
alsin [NCBI] 6.26133e-06
HLCS [NCBI] 6.26133e-06
ACTG1 [NCBI] 6.26133e-06
TPH2 [NCBI] 6.26133e-06
EIF2B5 [NCBI] 6.26133e-06
NAGA [NCBI] 6.26133e-06
ADA [NCBI] 6.21591e-06
PNMT [NCBI] 6.12064e-06
AHC [NCBI] 6.09597e-06
gaucher disease, type iii [NCBI] 6.09597e-06
charge syndrome [NCBI] 6.09597e-06
FMF [NCBI] 6.08829e-06
ABL [NCBI] 5.9111e-06
DM2 [NCBI] 5.9111e-06
CD14 [NCBI] 5.90171e-06
PLA2G7 [NCBI] 5.90171e-06
3-@hydroxy-3-methylglutaryl-coa lyase deficiency [NCBI] 5.90171e-06
HSPG2 [NCBI] 5.90171e-06
SCN2A [NCBI] 5.90171e-06
HABP2 [NCBI] 5.90171e-06
SCZD [NCBI] 5.82024e-06
osteogenesis imperfecta, type i [NCBI] 5.75283e-06
SOD1 [NCBI] 5.62841e-06
THBS1 [NCBI] 5.57049e-06
KCNQ2 [NCBI] 5.57049e-06
ADHD [NCBI] 5.53435e-06
CDK2 [NCBI] 5.49576e-06
VMD [NCBI] 5.46668e-06
LI1 [NCBI] 5.46668e-06
kindler syndrome [NCBI] 5.45627e-06
corneal dystrophy, gelatinous drop-like [NCBI] 5.45627e-06
GBD1 [NCBI] 5.45627e-06
sialuria [NCBI] 5.45627e-06
erythermalgia, primary [NCBI] 5.45627e-06
CTLN2 [NCBI] 5.45627e-06
WZS [NCBI] 5.45627e-06
hyperornithinemia-hyperammonemia-homocitrullinuria syndrome [NCBI] 5.45627e-06
alport syndrome, autosomal recessive [NCBI] 5.45627e-06
alzheimer disease 4 [NCBI] 5.45627e-06
renal tubular acidosis, distal, with progressive nerve deafness [NCBI] 5.45627e-06
ATLD [NCBI] 5.45627e-06
CDB1 [NCBI] 5.45627e-06
renal tubular acidosis, distal, autosomal dominant [NCBI] 5.45627e-06
HDC [NCBI] 5.40773e-06
lynch syndrome i [NCBI] 5.40282e-06
GAL [NCBI] 5.40167e-06
diabetes insipidus, nephrogenic, x-linked [NCBI] 5.36921e-06
RPGR [NCBI] 5.32268e-06
PANK2 [NCBI] 5.26411e-06
SGCA [NCBI] 5.26411e-06
PLIN [NCBI] 5.26411e-06
NPHS1 [NCBI] 5.26411e-06
TPH1 [NCBI] 5.26411e-06
CHH [NCBI] 5.22242e-06
gaucher disease, type i [NCBI] 5.22242e-06
VHL [NCBI] 5.19791e-06
JMML [NCBI] 5.14293e-06
HAE [NCBI] 5.03338e-06
CCR2 [NCBI] 4.97964e-06
RTN4 [NCBI] 4.97964e-06
SERPINA6 [NCBI] 4.92941e-06
AIS [NCBI] 4.74883e-06
VCAM1 [NCBI] 4.71465e-06
GLRA1 [NCBI] 4.71465e-06
PAPPA [NCBI] 4.71465e-06
ADSL [NCBI] 4.71465e-06
PTS [NCBI] 4.71465e-06
OKS [NCBI] 4.70673e-06
RSTS [NCBI] 4.61172e-06
MMP12 [NCBI] 4.46708e-06
PQBP1 [NCBI] 4.46708e-06
SGCE [NCBI] 4.46708e-06
BIRC1 [NCBI] 4.44832e-06
MAG [NCBI] 4.39727e-06
CDL1 [NCBI] 4.35941e-06
PFHB1A [NCBI] 4.35941e-06
GINGF [NCBI] 4.35941e-06
WS3 [NCBI] 4.35941e-06
kawasaki disease [NCBI] 4.35941e-06
wagr syndrome [NCBI] 4.35941e-06
IFD [NCBI] 4.35941e-06
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase [NCBI] 4.23519e-06
phenylketonuria ii [NCBI] 4.23519e-06
GPT [NCBI] 4.22446e-06
GCCR [NCBI] 4.22446e-06
SMEI [NCBI] 4.20229e-06
SPINK1 [NCBI] 4.18069e-06
krabbe disease [NCBI] 4.09574e-06
SSTR2 [NCBI] 4.01748e-06
FLT3 [NCBI] 4.01748e-06
DRD3 [NCBI] 4.01748e-06
ANXA1 [NCBI] 4.01748e-06
SLC2A1 [NCBI] 4.01748e-06
DSP [NCBI] 4.01748e-06
ALD [NCBI] 3.9165e-06
BRCA1 [NCBI] 3.88314e-06
AMPD1 [NCBI] 3.81266e-06
HLA-DQB1 [NCBI] 3.81266e-06
FOXC2 [NCBI] 3.81266e-06
F12 [NCBI] 3.81266e-06
DKC1 [NCBI] 3.81266e-06
PLG [NCBI] 3.76181e-06
PEDF [NCBI] 3.6395e-06
CTSB [NCBI] 3.61961e-06
LTC4S [NCBI] 3.61961e-06
RHD [NCBI] 3.61961e-06
MRE11A [NCBI] 3.61961e-06
FGF7 [NCBI] 3.61006e-06
TLR2 [NCBI] 3.60157e-06
CDLS1 [NCBI] 3.57455e-06
apert syndrome [NCBI] 3.5557e-06
DFNA6 [NCBI] 3.44553e-06
SFD [NCBI] 3.44553e-06
congenital cataracts, facial dysmorphism, and neuropathy [NCBI] 3.44553e-06
HOMG [NCBI] 3.44553e-06
encephalopathy, neonatal severe, due to mecp2 mutations [NCBI] 3.44553e-06
HHS [NCBI] 3.44553e-06
CLN5 [NCBI] 3.44553e-06
abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism [NCBI] 3.44553e-06
SNDI [NCBI] 3.44553e-06
CMT4A [NCBI] 3.44553e-06
methylmalonic aciduria and homocystinuria, cblc type [NCBI] 3.44553e-06
SMA4 [NCBI] 3.44553e-06
CMT2B [NCBI] 3.44553e-06
hemangioma-thrombocytopenia syndrome [NCBI] 3.44553e-06
BIRC5 [NCBI] 3.43735e-06
CTNS [NCBI] 3.4227e-06
myoclonic epilepsy of unverricht and lundborg [NCBI] 3.4227e-06
KCNH2 [NCBI] 3.36463e-06
GTS [NCBI] 3.3337e-06
LNS [NCBI] 3.30913e-06
MMP1 [NCBI] 3.26501e-06
TGM1 [NCBI] 3.26501e-06
CRP [NCBI] 3.26501e-06
HLA-DRB1 [NCBI] 3.26501e-06
SRD5A2 [NCBI] 3.26501e-06
danubian endemic familial nephropathy [NCBI] 3.221e-06
EEC1 [NCBI] 3.22097e-06
ETS1 [NCBI] 3.10184e-06
HTR2A [NCBI] 3.10184e-06
MTM1 [NCBI] 3.10184e-06
RP3 [NCBI] 3.05894e-06
MCOPS7 [NCBI] 3.05894e-06
homocysteinemia [NCBI] 3.05894e-06
lactase persistence [NCBI] 3.05394e-06
LFS1 [NCBI] 3.05394e-06
COH1 [NCBI] 3.05394e-06
OCA1A [NCBI] 3.05394e-06
hla-d histocompatibility type [NCBI] 2.99289e-06
SPP1 [NCBI] 2.94986e-06
SLC22A5 [NCBI] 2.94714e-06
CRYAB [NCBI] 2.94714e-06
MVK [NCBI] 2.94714e-06
CREB1 [NCBI] 2.94714e-06
NF2 [NCBI] 2.9397e-06
sickle cell anemia [NCBI] 2.9397e-06
COMT [NCBI] 2.83135e-06
contractural arachnodactyly, congenital [NCBI] 2.80032e-06
PROP1 [NCBI] 2.80032e-06
TIMP3 [NCBI] 2.80032e-06
TF [NCBI] 2.7759e-06
MDLS [NCBI] 2.70023e-06
CMTX1 [NCBI] 2.70023e-06
OPD1 [NCBI] 2.68402e-06
multiple pterygium syndrome, escobar variant [NCBI] 2.68402e-06
CDGG1 [NCBI] 2.68402e-06
heart block, congenital [NCBI] 2.68402e-06
pick disease of brain [NCBI] 2.68402e-06
thiopurine s-methyltransferase deficiency [NCBI] 2.68402e-06
CMT2A1 [NCBI] 2.68402e-06
XFS [NCBI] 2.68402e-06
argininosuccinic aciduria [NCBI] 2.68402e-06
ALS2 [NCBI] 2.68402e-06
pituitary dwarfism due to isolated growth hormone deficiency, autosomal dominant [NCBI] 2.68402e-06
acyl-coa dehydrogenase, short-chain, deficiency of [NCBI] 2.68402e-06
sacral defect with anterior meningocele [NCBI] 2.68402e-06
ARX [NCBI] 2.66083e-06
CALCA [NCBI] 2.66083e-06
KRT14 [NCBI] 2.66083e-06
ornithine transcarbamylase deficiency, hyperammonemia due to [NCBI] 2.64083e-06
BCPM [NCBI] 2.60994e-06
PYY [NCBI] 2.54278e-06
PI [NCBI] 2.54043e-06
PMP22 [NCBI] 2.53453e-06
PROS1 [NCBI] 2.52819e-06
ABCC1 [NCBI] 2.47305e-06
SST [NCBI] 2.46238e-06
TWIST1 [NCBI] 2.40194e-06
porphyria variegata [NCBI] 2.3821e-06
SVAS [NCBI] 2.3821e-06
MM [NCBI] 2.36245e-06
CADASIL [NCBI] 2.36245e-06
walker-warburg syndrome [NCBI] 2.36245e-06
TLR4 [NCBI] 2.29482e-06
EV [NCBI] 2.28845e-06
FTL [NCBI] 2.2817e-06
GCH1 [NCBI] 2.2817e-06
IL18 [NCBI] 2.2817e-06
periodic fever, familial, autosomal dominant [NCBI] 2.20554e-06
DJS [NCBI] 2.20554e-06
LBP [NCBI] 2.20412e-06
phenylketonuria [NCBI] 2.19765e-06
oca2 gene [NCBI] 2.16709e-06
MAOB [NCBI] 2.16709e-06
MTND6 [NCBI] 2.16709e-06
SHBG [NCBI] 2.16312e-06
NIDDM [NCBI] 2.13415e-06
BCHE [NCBI] 2.13276e-06
AGS1 [NCBI] 2.05137e-06
OPD2 [NCBI] 2.05137e-06
HMN5 [NCBI] 2.05137e-06
LGMD1B [NCBI] 2.05137e-06
methionine adenosyltransferase deficiency [NCBI] 2.05137e-06
cerebrotendinous xanthomatosis [NCBI] 2.05137e-06
gm1-gangliosidosis, type iii [NCBI] 2.05137e-06
anemia, dyserythropoietic congenital, type i [NCBI] 2.05137e-06
myoclonic dystonia [NCBI] 2.04152e-06
MEN1 [NCBI] 2.01939e-06
SDS [NCBI] 1.96319e-06
MS [NCBI] 1.96224e-06
anemia, sideroblastic, x-linked [NCBI] 1.95349e-06
CREM [NCBI] 1.95349e-06
PPOX [NCBI] 1.95349e-06
PEPD [NCBI] 1.95349e-06
VDR [NCBI] 1.91571e-06
PIGA [NCBI] 1.85391e-06
RB1 [NCBI] 1.79887e-06
PF4 [NCBI] 1.77232e-06
PTHR1 [NCBI] 1.7588e-06
PAI1 [NCBI] 1.7588e-06
BCL6 [NCBI] 1.7588e-06
diaphragmatic hernia, congenital [NCBI] 1.7564e-06
costello syndrome [NCBI] 1.73847e-06
PKS [NCBI] 1.73847e-06
PARK2 [NCBI] 1.73847e-06
CVS [NCBI] 1.73847e-06
SPG3A [NCBI] 1.73847e-06
glycogen storage disease vii [NCBI] 1.73847e-06
PGL1 [NCBI] 1.73847e-06
PTGS2 [NCBI] 1.68482e-06
EIG [NCBI] 1.68422e-06
RDT [NCBI] 1.67208e-06
GK [NCBI] 1.66793e-06
ASPA [NCBI] 1.66793e-06
glycogen storage disease i [NCBI] 1.66793e-06
hemophilia a [NCBI] 1.58371e-06
HDGF [NCBI] 1.58107e-06
ABO [NCBI] 1.58107e-06
CTGF [NCBI] 1.53457e-06
TYR [NCBI] 1.53363e-06
propionic acidemia [NCBI] 1.52911e-06
hypophosphatasia, adult type [NCBI] 1.52911e-06
tibial muscular dystrophy, tardive [NCBI] 1.52911e-06
ichthyosis congenita, harlequin fetus type [NCBI] 1.52911e-06
succinic semialdehyde dehydrogenase deficiency [NCBI] 1.52911e-06
glutaric acidemia i [NCBI] 1.52911e-06
CML [NCBI] 1.51948e-06
EVA [NCBI] 1.51948e-06
CMD1A [NCBI] 1.51948e-06
RHCE [NCBI] 1.49803e-06
SGBS1 [NCBI] 1.45442e-06
EKD1 [NCBI] 1.41939e-06
STK11 [NCBI] 1.41861e-06
UMOD [NCBI] 1.41861e-06
GRN [NCBI] 1.41861e-06
FGFR2 [NCBI] 1.36852e-06
CPB2 [NCBI] 1.34735e-06
CSF2 [NCBI] 1.34265e-06
protoporphyria, erythropoietic [NCBI] 1.34265e-06
PG [NCBI] 1.30338e-06
MMP3 [NCBI] 1.26999e-06
FOLH1 [NCBI] 1.26999e-06
mucopolysaccharidosis type iva [NCBI] 1.26999e-06
CTLA4 [NCBI] 1.26999e-06
ARMD1 [NCBI] 1.25776e-06
CASR [NCBI] 1.25023e-06
MCP [NCBI] 1.25023e-06
ACP5 [NCBI] 1.24772e-06
CDPX2 [NCBI] 1.23291e-06
CLL [NCBI] 1.23291e-06
ADM [NCBI] 1.20197e-06
ADIPOQ [NCBI] 1.20047e-06
PLK1 [NCBI] 1.19243e-06
SOX9 [NCBI] 1.13396e-06
ASPS [NCBI] 1.10249e-06
GCE [NCBI] 1.10249e-06
TTP [NCBI] 1.10249e-06
hartnup disorder [NCBI] 1.10249e-06
NBIA1 [NCBI] 1.10249e-06
infantile sialic acid storage disorder [NCBI] 1.10249e-06
IVA [NCBI] 1.10249e-06
MAOA [NCBI] 1.09821e-06
GSR [NCBI] 1.07032e-06
HFE [NCBI] 1.02964e-06
PLAUR [NCBI] 1.02267e-06
PPR [NCBI] 1.0161e-06
porphyria cutanea tarda [NCBI] 1.00944e-06
GIP [NCBI] 9.76444e-07
MECP2 [NCBI] 9.70711e-07
ABCB1 [NCBI] 9.70711e-07
APCS [NCBI] 9.51196e-07
TNFRSF6 [NCBI] 9.51196e-07
TCF7L2 [NCBI] 9.51196e-07
STL1 [NCBI] 9.48315e-07
graves disease [NCBI] 9.48315e-07
AGER [NCBI] 8.91703e-07
LQT1 [NCBI] 8.61031e-07
UCP1 [NCBI] 8.15094e-07
WBS [NCBI] 8.14099e-07
RP2 [NCBI] 7.91242e-07
factor vii deficiency [NCBI] 7.91242e-07
neuraminidase deficiency [NCBI] 7.6198e-07
PHA [NCBI] 7.59544e-07
OPTB3 [NCBI] 7.59544e-07
hyperlipoproteinemia, type i [NCBI] 7.59544e-07
acromegaly [NCBI] 7.59544e-07
diarrhea 1, secretory chloride, congenital [NCBI] 7.59544e-07
mucopolysaccharidosis type iiia [NCBI] 7.59544e-07
SCZD1 [NCBI] 7.59544e-07
TMAU [NCBI] 7.59544e-07
pituitary dwarfism iii [NCBI] 7.59544e-07
DSG3 [NCBI] 7.42533e-07
hurler syndrome [NCBI] 7.33471e-07
STGD1 [NCBI] 7.291e-07
RP1 [NCBI] 7.291e-07
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i [NCBI] 7.291e-07
alport syndrome, autosomal dominant [NCBI] 7.07765e-07
CSF3 [NCBI] 6.95984e-07
KDR [NCBI] 6.69475e-07
CCND1 [NCBI] 6.67401e-07
PCD [NCBI] 6.35057e-07
ALK [NCBI] 6.13161e-07
MTM1 [NCBI] 5.86591e-07
RCC1 [NCBI] 5.86591e-07
BRCA2 [NCBI] 5.78376e-07
aHUS [NCBI] 5.73861e-07
TFRC [NCBI] 5.68515e-07
NS1 [NCBI] 5.62777e-07
SLPI [NCBI] 5.56389e-07
PNPLA6 [NCBI] 5.56389e-07
BCNS [NCBI] 5.38863e-07
RET [NCBI] 5.34726e-07
PHS [NCBI] 5.34587e-07
HSAS [NCBI] 5.34587e-07
DAR [NCBI] 5.34587e-07
C3 [NCBI] 5.29846e-07
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant [NCBI] 4.90401e-07
OFD1 [NCBI] 4.90401e-07
EA2 [NCBI] 4.90401e-07
leopard syndrome 1 [NCBI] 4.90401e-07
FHM2 [NCBI] 4.90401e-07
BGS [NCBI] 4.90401e-07
camurati-engelmann disease [NCBI] 4.90401e-07
weaver syndrome [NCBI] 4.90401e-07
factor xii deficiency [NCBI] 4.90401e-07
F3 [NCBI] 4.82106e-07
SLC2A2 [NCBI] 4.57847e-07
wilson disease [NCBI] 4.5729e-07
ARPKD [NCBI] 4.5455e-07
bullous erythroderma ichthyosiformis congenita of brocq [NCBI] 4.5455e-07
CDKN2A [NCBI] 4.31449e-07
TNC [NCBI] 4.22602e-07
SLC6A4 [NCBI] 4.16453e-07
HHF1 [NCBI] 4.15056e-07
CDH1 [NCBI] 3.92576e-07
KCNQ1 [NCBI] 3.92576e-07
ALPS [NCBI] 3.8689e-07
PTN [NCBI] 3.73702e-07
MAPT [NCBI] 3.73702e-07
RCDP1 [NCBI] 3.66606e-07
FHM1 [NCBI] 3.66606e-07
OPTB1 [NCBI] 3.66606e-07
WT1 [NCBI] 3.62327e-07
KRAS [NCBI] 3.62327e-07
MTND4 [NCBI] 3.62327e-07
ITGB3 [NCBI] 3.33601e-07
cortisol 11-beta-ketoreductase deficiency [NCBI] 3.33601e-07
RHO [NCBI] 3.24616e-07
UCP2 [NCBI] 3.19305e-07
TPMT [NCBI] 3.19305e-07
GJB1 [NCBI] 3.19305e-07
HPRT1 [NCBI] 3.01945e-07
CFH [NCBI] 3.01945e-07
PCLD [NCBI] 2.8685e-07
IBM2 [NCBI] 2.8685e-07
osteogenesis imperfecta, type iv [NCBI] 2.8685e-07
VWM [NCBI] 2.8685e-07
pancreatic carcinoma [NCBI] 2.8685e-07
hypophosphatemic rickets, x-linked dominant [NCBI] 2.84042e-07
CP [NCBI] 2.79683e-07
JAK2 [NCBI] 2.77515e-07
CPI [NCBI] 2.71278e-07
ESR1 [NCBI] 2.68422e-07
EIF4E [NCBI] 2.56101e-07
SPARC [NCBI] 2.56101e-07
PPARG [NCBI] 2.52272e-07
PAM [NCBI] 2.52272e-07
HHF2 [NCBI] 2.37373e-07
maple syrup urine disease [NCBI] 2.37373e-07
COL1A1 [NCBI] 2.36539e-07
ABCC8 [NCBI] 2.36539e-07
lung cancer [NCBI] 2.27197e-07
HNFJ [NCBI] 2.27197e-07
hepatocellular carcinoma [NCBI] 2.27197e-07
PON1 [NCBI] 2.2644e-07
CCL17 [NCBI] 2.11235e-07
PTHLH [NCBI] 2.0463e-07
CDSP [NCBI] 1.7941e-07
GRA [NCBI] 1.53522e-07
ANG [NCBI] 1.53363e-07
GPI [NCBI] 1.43774e-07
PARK8 [NCBI] 1.4198e-07
autonomic control, congenital failure of [NCBI] 1.4198e-07
MSS [NCBI] 1.4198e-07
MEN2B [NCBI] 1.4198e-07
MAS [NCBI] 1.38296e-07
DRD4 [NCBI] 1.2066e-07
TSC2 [NCBI] 1.2066e-07
MHA [NCBI] 1.18647e-07
CFNS [NCBI] 1.18647e-07
MELAS [NCBI] 1.18647e-07
FDH [NCBI] 1.18647e-07
SEDC [NCBI] 1.18647e-07
MCDR1 [NCBI] 1.16572e-07
chiari malformation type i [NCBI] 1.16572e-07
SI [NCBI] 1.1493e-07
adrenoleukodystrophy, autosomal neonatal form [NCBI] 9.98586e-08
IL6 [NCBI] 9.62261e-08
GHRH [NCBI] 8.7371e-08
LEP [NCBI] 8.73391e-08
hypertrophic neuropathy of dejerine-sottas [NCBI] 8.70862e-08
MBL2 [NCBI] 8.13757e-08
alopecia, androgenetic [NCBI] 7.92838e-08
CVID [NCBI] 7.38389e-08
PARK2 [NCBI] 6.82487e-08
APL [NCBI] 4.99144e-08
CGL2 [NCBI] 4.99144e-08
ETM1 [NCBI] 4.99144e-08
gm1-gangliosidosis, type i [NCBI] 4.99144e-08
osteogenesis imperfecta, type iii [NCBI] 4.99144e-08
SCA17 [NCBI] 4.99144e-08
ACADM [NCBI] 4.97674e-08
UGB [NCBI] 4.80965e-08
GH1 [NCBI] 4.78856e-08
TTR [NCBI] 4.46945e-08
porphyria, acute intermittent [NCBI] 4.41778e-08
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency [NCBI] 4.36507e-08
biotinidase deficiency [NCBI] 4.35289e-08
LIP [NCBI] 4.35289e-08
osteoporosis [NCBI] 4.35289e-08
HOKPP [NCBI] 4.35289e-08
MTTL1 [NCBI] 3.9445e-08
CCL22 [NCBI] 3.9445e-08
CSA [NCBI] 3.88148e-08
neuroblastoma [NCBI] 3.88148e-08
ABCB11 [NCBI] 3.36723e-08
ABP1 [NCBI] 3.25168e-08
PSEN1 [NCBI] 2.76171e-08
HP [NCBI] 1.78997e-08
MTHFR [NCBI] 1.38036e-08
EDMD [NCBI] 1.12444e-08
SCA6 [NCBI] 9.50605e-09
antithrombin iii deficiency [NCBI] 8.66732e-09
APS1 [NCBI] 5.96007e-09
cardiofaciocutaneous syndrome [NCBI] 5.62046e-09
mucolipidosis iv [NCBI] 5.62046e-09
megaloblastic anemia 1 [NCBI] 5.62046e-09
mucopolysaccharidosis type vi [NCBI] 5.62046e-09
PSNP1 [NCBI] 4.75152e-09
bartter syndrome, type 3 [NCBI] 4.75152e-09
EKV [NCBI] 4.75152e-09
sudden infant death syndrome [NCBI] 4.75152e-09
DRD [NCBI] 4.75152e-09
niemann-pick disease, type a [NCBI] 4.75152e-09
TGD [NCBI] 4.75152e-09
CDK4 [NCBI] 4.36665e-09
ZFP36 [NCBI] 3.40174e-09
SMN1 [NCBI] 3.14262e-09
COL2A1 [NCBI] 3.14262e-09
menkes disease [NCBI] 2.11059e-09
AMH [NCBI] 1.84483e-09
TPO [NCBI] 4.04327e-10
DYT1 [NCBI] 1.22447e-11
SCS [NCBI] 1.22447e-11



Database Center for Life Science